Point72 Asset Management’s Novartis NVS Stock Holding History

Point72 Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.69M	Buy	43,800 +4,900	+13%	+$751K	0.01%	1502
2025 Q4	$5.36M	Buy	38,900 +8,100	+26%	+$1.06M	0.01%	1792
2025 Q3	$3.95M	Hold	30,800	–	–	0.01%	1163
2025 Q2	$3.73M	Sell	30,800 -100,900	-77%	-$11.4M	0.01%	1064
2025 Q1	$14.7M	Buy	131,700 +100,900	+328%	+$10.7M	0.03%	542
2024 Q4	$3M	Buy	30,800 +100	+0.3%	+$10.7K	0.01%	1104
2024 Q3	$3.53M	Buy	+30,700	New	+$3.48M	0.01%	979
2024 Q1	–	Sell	-18,500	Closed	-$1.87M	–	2490
2023 Q4	$1.87M	Hold	18,500	–	–	﹤0.01%	1235
2023 Q3	$1.88M	Sell	18,500 -421,900	-96%	-$42.8M	0.01%	1140
2023 Q2	$44.4M	Buy	440,400 +421,900	+2,281%	+$42.2M	0.13%	196
2023 Q1	$1.7M	Buy	+18,500	New	+$1.62M	0.01%	1008

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management's NVS Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Novartis (NVS) in Q1 2026: 283,837 shares worth $43.4M. The stake represents 0.06% of the portfolio and ranks #432 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in NVS as recently as Q2 2025.

Point72 Asset Management first reported a position in NVS in Q2 2014 and has held it in 22 quarters since. The position peaked at $167M in Q1 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Point72 Asset Management held 283,837 shares of Novartis worth $43.4M as of Q1 2026.
Novartis was a new Point72 Asset Management position in Q1 2026.
Novartis made up 0.06% of Point72 Asset Management's portfolio in Q1 2026, its #432 holding.
Point72 Asset Management first reported a position in Novartis in Q2 2014 and has held it in 22 quarters since.
Point72 Asset Management's Novartis position peaked at $167M in Q1 2023.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.